RT Journal Article
SR Electronic
T1 Methylation scores for smoking, alcohol consumption, and body mass index and risk of seven types of cancer
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.08.21251370
DO 10.1101/2021.02.08.21251370
A1 Dugué, Pierre-Antoine
A1 Yu, Chenglong
A1 Hodge, Allison M
A1 Wong, Ee Ming
A1 Joo, JiHoon E
A1 Jung, Chol-Hee
A1 Schmidt, Daniel
A1 Makalic, Enes
A1 Buchanan, Daniel D
A1 Severi, Gianluca
A1 English, Dallas R
A1 Hopper, John L
A1 Milne, Roger L
A1 Giles, Graham G
A1 Southey, Melissa C
YR 2021
UL http://medrxiv.org/content/early/2021/02/10/2021.02.08.21251370.abstract
AB Methylation marks of exposure to health risk factors may be useful markers of cancer risk as they might better capture current and past exposures than questionnaires, and reflect different individual responses to exposure. We used data from seven case-control studies nested within the Melbourne Collaborative Cohort Study of blood DNA methylation and risk of colorectal, gastric, kidney, lung, prostate and urothelial cancer, and B-cell lymphoma (N cases=3,123). Methylation scores (MS) for smoking, body mass index (BMI), and alcohol consumption were calculated based on published data as weighted averages of methylation values. Rate ratios (RR) and 95% confidence intervals for association with cancer risk were estimated using conditional logistic regression and expressed per standard deviation increase of the MS, with and without adjustment for health-related confounders. The contribution of MS to discriminate cases from controls was evaluated using the area under the curve (AUC). After confounder adjustment, we observed: large associations (RR∼1.5-1.7) with lung cancer risk for smoking MS; moderate associations (RR∼1.2-1.3) with urothelial cancer risk for smoking MS and with mature B-cell neoplasm risk for BMI and alcohol MS; moderate to small associations (RR∼1.1-1.2) for BMI and alcohol MS with several cancer types and cancer overall. Generally small AUC increases were observed after inclusion of several MS in the same model (colorectal, gastric, kidney, urothelial cancers: +3%; lung cancer: +7%; B-cell neoplasms: +8%). Methylation scores for smoking, BMI, and alcohol consumption show independent associations with cancer risk, and may provide some improvements in risk prediction.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Australian National Health and Medical Research Council (NHMRC) grant 1164455. MCCS cohort recruitment was funded by VicHealth and Cancer Council Victoria. The MCCS was further supported by Australian NHMRC grants 209057, 251553 and 504711 and by infrastructure provided by Cancer Council Victoria. The nested case-control methylation studies were supported by the NHMRC grants 1011618, 1026892, 1027505, 1050198, 1043616 and 1074383. M.C.S. is an NHMRC Senior Research Fellow (1061177).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of Cancer Council Victoria. All participants have provided written informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data and code used in this study are available from the corresponding author upon reasonable request.AHRRaryl hydrocarbon receptor repressorAUCarea under the receiver operating characteristic curveBMIbody mass indexEWASepigenome-wide association studyMCCSMelbourne Collaborative Cohort StudyMSmethylation scoreSDstandard deviation,